Amyris Inc  

(Public, NASDAQ:AMRS)   Watch this stock  
Find more results for AMRS
2.27
-0.03 (-1.30%)
Dec 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.25 - 2.39
52 week 2.03 - 6.11
Open 2.27
Vol / Avg. 292,760.00/159,235.00
Mkt cap 179.50M
P/E     -
Div/yield     -
EPS -2.53
Shares 79.08M
Beta 1.75
Inst. own 51%
Feb 23, 2015
Q4 2014 Amyris Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 4, 2014
Q3 2014 Amyris Inc Earnings Call
Nov 4, 2014
Q3 2014 Amyris Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -224.42% -571.29%
Operating margin -130.31% -339.33%
EBITD margin - -227.66%
Return on average assets -54.20% -106.37%
Return on average equity - -
Employees 392 -
CDP Score - -

Address

SUITE 100, 5885 HOLLIS ST
EMERYVILLE, CA 94608
United States - Map
+1-510-4500761 (Phone)
+1-510-2252645 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amyris, Inc., formerly Amyris Biotechnologies, Inc. develops and provides renewable compounds for a variety of markets. As of December 31, 2012, the Company built and applied its industrial synthetic biology platform to provide alternatives to petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. The Company is focused on developing a range of products to address six markets: cosmetics, lubricants, flavors and fragrances, polymers, consumer products and transportation fuels. The Company�s call these No Compromise products because it design them to perform comparably to, or better than, available products. It genetically modifies micro organisms, primarily yeast, and uses them as living factories in established fermentation processes to convert plant-sourced sugars into thousands of molecules. The Company has two operating subsidiaries, Amyris Brasil Ltda. (formerly Amyris Brasil S.A.), or Amyris Brasil, and Amyris Fuels LLC, or Amyris Fuels.

Officers and directors

John G. Melo President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Paulo Diniz Interim Chief Financial Officer; Chief Executive Officer of Amyris Brasil Ltda.
Age: 56
Bio & Compensation  - Reuters
Joel Cherry Ph.D. President - Research and Development
Age: 53
Bio & Compensation  - Reuters
Karen D. Rohde Chief Human Resources Officer
Bio & Compensation  - Reuters
Jack Newman Ph.D. Chief Science Officer
Bio & Compensation  - Reuters
Nicholas Khadder General Counsel, Corporate Secretary
Age: 40
Bio & Compensation  - Reuters
Zanna McFerson Chief Business Officer
Age: 48
Bio & Compensation  - Reuters
Philippe Boisseau Director
Age: 52
Bio & Compensation  - Reuters
Patrick Y. Yang Ph.D. Director
Age: 66
Bio & Compensation  - Reuters
Abdullah Bin Khalifa Al Thani Independent Director
Age: 54
Bio & Compensation  - Reuters